Fatima Bosch

Dr. Bosch is currently Full Professor of Biochemistry and Molecular Biology and Director of the Center of Animal Biotechnology and Gene Therapy at the Universitat Autònoma de Barcelona. She was a founding member of the European Society of Gene and Cell Therapy, President of the Spanish Society of Gene and Cell Therapy and Vice-President of the European Association for the Study of Diabetes. Dr. Bosch is also a member of the Gene Doping Expert Group of the World Anti-Doping Agency.

Dr. Bosch’s research focuses on developing AAV-mediated gene therapy approaches for highly prevalent metabolic and neurodegenerative diseases. Dr. Bosch has also been involved in the development of gene therapies for severe inherited metabolic and neurodegenerative disorders, such as Mucopolysaccharidosis (MPS).

Dr. Bosch received her PhD in biochemistry and molecular biology and her undergraduate degree in pharmacy from the University of Barcelona. Dr. Bosch conducted post-doctoral studies at Vanderbilt University, Case Western Reserve University, and the NCI-Frederick Cancer Research and Development Center